Eric Lefkofsky’s Healthcare Startup Tempus Just Received $70 Million to Develop Data-Driven Cancer Treatment Plans

Eric Lefkofsky is a highly respected entrepreneur in the technology world. While he is best known for founding the unicorn of big data startups Uptake Technologies as well as Groupon, he has shifted his focus to utilize big data and technology to help develop cancer care treatments that are customized to the patient and what Eric knows.

Eric is known for developing companies that are on the cusp of emerging technologies and data. Those who work closely with him know that he is a solution oriented leader that doesn’t shy away from taking it upon himself and key team members to solve issues that affect people globally. Among his companies is Lightbank. Lightbank is a new kind of investment company that seeks out “disruptors” in the tech industry and funds their goal driven companies.

In the founding and leading of Tempus, Eric is seeking to build the world’s largest library of cancer related molecular and clinical data. Tempus is all about data and for the first time it will allow physicians to provide a treatment plan that is data driven and more information click here.

It is astounding that with all the cancer research and clinical research collected from past patients there is no central operations system that allows physicians from anywhere in the world to make use of past data when developing current patient treatment plans. The collection and centralization of that data, paired with human genome data collection, means that for the first time this wealth of data will be available in one digital system. Basically, by collecting data from everywhere in the world, a physician in Tuscon will have access to the findings and genome data of a cancer patient in Detroit, and so on and so on.

In a recent announcement, Tempus shared that the company had received $70 million in its latest Series C funding. This investment, paired with its previous funding rounds, has garnered $130 million for the company and now brings the valuation to an estimated $700 million. This shows incredible promise for Tempus, which is just 2 years old and has by far exceeded the line to make it a tech unicorn startup and Eric Lefkofsky’s lacrosse camp.

With Eric Lefkofsky at the helm, Tempus will continue to grow and hopefully succees in helping physicians provide highly customized, data-driven cancer treatment plans and https://www.tempus.com/about-us/.

Leave a Reply

Your email address will not be published. Required fields are marked *